NorthWest Biotherapeutics Inc (NWBO)

[ccie1024]

In particular, the results of this study show that IDH1 mutant gliomas are less vulnerable to radiation-induced DNA damage which draws into question the efficacy of radiation therapy for this subset of tumors.

With apology if it has already been posted:

Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities

https://link.springer.com/article/10.1186/s40170-018-0177-4